Patent Assignment
Reel/Frame 047294/0065
Security Interest
Recorded: 2018-10-24
Pages: 23
Assignor
ELCELYX THERAPEUTICS, INC.
Executed: 2018-10-22
Assignees
TRIUMPH INTERNATIONAL INVESTMENT LTD.
C/O UNIT 2006-08, 20/F HARBOUR CENTRE, 25 HARBOUR ROAD, WAN CHAI, HONG KONG
GSM FUND LLC
3033 SCIENCE PARK ROAD, SUITE 230, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(26)
Chemosensory Receptor Ligand-Based Therapies
PCT:
PCT/US2012/020548 ↗
Biguanide Compositions and Methods of Treating Metabolic Disorders
PCT:
PCT/US2012/046335 ↗
Compositions and Methods for Treating Metabolic Disorders
PCT:
PCT/US2013/020420 ↗
Compositions and Methods for Reducing Cardiometabolic Risk
PCT:
PCT/US2013/050142 ↗
Compositions and Methods for Treating Metabolic Disorders
PCT:
PCT/US2014/010240 ↗
Chemosensory Receptor Ligand-Based Therapies
Application:
13/345,135 →
Publication:
US 2012/0177730
Biguanide Compositions and Methods of Treating Metabolic Disorders
Compositions and Methods of Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Compositions and Methods for Treating Metabolic Disorders
Application:
14/147,449 →
Publication:
US 2014/0193498
Biguanide Compositions and Methods of Treating Metabolic Disorders
Compositions and Methods for Treating Metabolic Disorders
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk
Biguanide Compositions and Methods of Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Compositions and Methods for Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Biguanide Compositions and Methods of Treating Metabolic Disorders
Biguanide Compositions and Methods of Treating Metabolic Disorders
Compositions Comprising Statins, Biguanides and Further Agents for Reducing Cardiometabolic Risk
Compositions and Methods for Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Biguanide Compositions and Methods of Treating Metabolic Disorders
Chemosensory Receptor Ligand-Based Therapies
Application:
61/430,914 →
Methods of Treating Metabolic Disorders in Patients
Application:
61/649,171 →
Compositions and Methods for Treating Metabolic Disorders
Application:
61/749,307 →
Related Assignments
(24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 7, 2012
From: BARON, ALAIN D.; BROWN, MARTIN R.; JONES, CHRISTOPHER R.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 027667/0559 →
Assignment of Assignor's Interest
Sep 3, 2014
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033661/0653 →
Assignment of Assignor's Interest
Sep 3, 2014
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033659/0038 →
Assignment of Assignor's Interest
Sep 5, 2014
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033678/0646 →
Assignment of Assignor's Interest
Sep 5, 2014
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 033678/0435 →
Assignment of Assignor's Interest
Jun 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; KIM, TERRI; DORDUNOO, STEPHEN KWAKU
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 035916/0722 →
Assignment of Assignor's Interest
Aug 12, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036313/0195 →
Assignment of Assignor's Interest
Aug 12, 2015
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036313/0167 →
Assignment of Assignor's Interest
Aug 26, 2015
From: BARON, ALAIN; BROWN, MARTIN R.; JONES, CHRISTOPHER R.G.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0392 →
Assignment of Assignor's Interest
Aug 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0950 →
Assignment of Assignor's Interest
Aug 26, 2015
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 036430/0922 →
Assignment of Assignor's Interest
Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041438/0736 →
Assignment of Assignor's Interest
Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041440/0348 →
Assignment of Assignor's Interest
Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041439/0807 →
Assignment of Assignor's Interest
Mar 2, 2017
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 041440/0202 →
Assignment of Assignor's Interest
Apr 14, 2017
From: BARON, ALAIN D.; BROWN, MARTIN R.; JONES, CHRISTOPHER R.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 042012/0525 →
Assignment of Assignor's Interest
Jul 24, 2019
From: BARON, ALAIN D.; FINEMAN, MARK S.; BEELEY, NIGEL R.A.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 049844/0952 →
Assignment of Assignor's Interest
Aug 5, 2019
From: ELCELYX THERAPEUTICS, INC.
To: ANJI PHARMA (US) LLC
Reel/Frame 049956/0454 →
Release of Security Interest
Apr 6, 2020
From: TRIUMPH INTERNATIONAL INVESTMENT LTD.; GSM FUND LLC
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 052322/0123 →
Release of Security Interest
Apr 6, 2020
From: TRIUMPH INTERNATIONAL INVESTMENT LTD.; GSM FUND LLC
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 052322/0028 →
Assignment of Assignor's Interest
Jul 17, 2020
From: BARON, ALAIN D.; BEELEY, NIGEL R.A.; FINEMAN, MARK S.
To: ELCELYX THERAPEUTICS, INC.
Reel/Frame 053240/0415 →
Assignment of Assignor's Interest
Oct 3, 2022
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 061287/0421 →
Assignment of Assignor's Interest
Mar 2, 2023
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 062859/0357 →
Assignment of Assignor's Interest
Mar 16, 2023
From: ANJI PHARMA (US) LLC
To: ANJI PHARMACEUTICALS INC.
Reel/Frame 063005/0199 →